Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).
about
Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Expert recommendation: contrib ...... hyperactivity disorder (ADHD).
@en
Expert recommendation: contrib ...... ug lisdexamfetamine dimesylate
@nl
type
label
Expert recommendation: contrib ...... hyperactivity disorder (ADHD).
@en
Expert recommendation: contrib ...... ug lisdexamfetamine dimesylate
@nl
prefLabel
Expert recommendation: contrib ...... hyperactivity disorder (ADHD).
@en
Expert recommendation: contrib ...... ug lisdexamfetamine dimesylate
@nl
P2093
P50
P1476
Expert recommendation: contrib ...... hyperactivity disorder (ADHD).
@en
P2093
Amaia Hervás
Anna Sans-Fitó
Esther Cardo-Jalón Cardo-Jalón
Isabel Hernández-Otero
Javier Sánchez
José A Alda
Lefa S Eddy-Ives
M Inés Hidalgo-Vicario
Maximino Fernández-Pérez
P478
P577
2014-12-01T00:00:00Z